Skip to main content

Chemomab Therapeutics Ltd ADR(CMMB-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Chemomab Therapeutics to Present at 2023 Aegis Virtual Conference

PR Newswire - Wed Apr 26, 2023

TEL AVIV, Israel, April 26, 2023 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that the company will participate in the Aegis Virtual Conference being held May 2โ€“May 4, 2023. Chemomab management will present a corporate overview on Wednesday, May 3, 2023.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe